(Q45399952)
Statements
Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients (English)
M Diago
A Olveira
R Pérez
R Bárcena
J M Sánchez-Tapias
M Muñoz-Sánchez